Centrexion is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of chronic pain.
$2.3M
Nov 13, 2023
-
CTI BioPharma is a Washington-based biopharmaceutical company that researches and develops novel therapies for the treatment of patients with blood cancer.
$10M
Dec 13, 2015
-
Wave Life Sciences develops next-generation nucleic acid drugs that achieve high systemic bioavailability.
$30M
Dec 13, 2015
-
Amwell is a Massachusetts-based telehealth platform that offers solutions such as text-based on-demand virtual primary care and behavioral health for individuals.
-
Jun 01, 2015
-
Ignyta develops and commercializes targeted molecule therapies for the treatment of cancer.
$42M
Mar 17, 2015
-
Frequently Asked Questions about TEVA
What is TEVA investing in?
TEVA has invested in 9 companies including Centrexion, CTI BioPharma and Wave Life Sciences
What company did TEVA invest in?
TEVA invested in a total 9 companies including Centrexion, CTI BioPharma and Wave Life Sciences
What are the top 5 investments by TEVA?
The top companies in which TEVA invested are Centrexion, CTI BioPharma, Wave Life Sciences, Amwell and Ignyta
